Only certain shapes work fast; the rest are just going through the motions
Within the invisible architecture of every living cell, proteins called scramblases perform a ceaseless shuffling of the membrane's molecular layers — a process so fundamental that without it, cells cannot build themselves, sustain themselves, or communicate. For decades, scientists could only observe this choreography in aggregate, averaging the behavior of crowds of proteins and losing the individual story in the noise. Now, researchers at Weill Cornell Medicine and Ruhr University Bochum have developed a fluorescence imaging technique that isolates a single scramblase and measures precisely how fast it works — opening a window onto biological variation that bulk methods could never reveal, and with it, new possibilities for understanding disease.
- The core limitation was invisibility: studying scramblases in bulk meant individual differences were erased by the average, leaving researchers blind to variation that could explain both normal function and failure.
- The new technique tags single proteins with fluorescent markers, embeds them in artificial membrane spheres, and uses precision microscopy to count exactly how many lipid molecules one protein moves per second.
- The results were striking — VDAC1 protein pairs scrambled anywhere from under 100 to over 1,000 lipids per second, confirming long-held computational predictions that only certain molecular shapes enable rapid activity.
- Opsin, a light receptor moonlighting as a scramblase, proved dramatically faster than VDAC1, exceeding 10,000 lipids per second — a tenfold difference that illustrates the platform's power to compare proteins as well as individuals.
- The technique now positions researchers to ask how membrane composition, drug binding, and protein shape each influence scramblase speed — and whether selectively tuning these proteins could one day treat disease.
Inside every cell membrane, proteins called scramblases perform one of biology's most essential yet underappreciated tasks: they shuffle the fat molecules that form the membrane's layered structure, enabling cells to assemble, survive, develop muscle, and move molecules where they are needed. For decades, scientists wanted to watch this process at the level of a single protein. They could not — until now.
Researchers at Weill Cornell Medicine and Ruhr University Bochum have developed the first fluorescence imaging technique capable of measuring individual scramblase activity, published in Nature Structural & Molecular Biology. The breakthrough lies in what it replaces: the old method studied scramblases in bulk, embedding many proteins into artificial membrane spheres and recording their collective behavior. Any variation between individual proteins was swallowed by the average. As Dr. Anant Menon, a senior author on the study, put it, researchers were missing potentially large differences between individual molecules — differences that could explain how these proteins function and why they sometimes fail.
The new approach tags scramblases with fluorescent markers, deposits protein-containing vesicles onto a glass slide, and uses sophisticated microscopy to identify vesicles holding exactly one scramblase, then measures its lipid-transport rate directly. Testing on two proteins revealed the technique's power immediately. VDAC1 — a mitochondrial channel protein recently discovered to also function as a scramblase — showed dramatic variation when two copies paired together: some pairs moved fewer than 100 lipids per second, others exceeded 1,000, confirming predictions from computer simulations that only certain molecular configurations enable rapid scrambling. Opsin, a light-detecting receptor that also moonlights as a scramblase, proved far faster still, exceeding 10,000 lipids per second.
The implications reach beyond measurement. With this precision, researchers can now ask how membrane composition or drug binding alters a scramblase's speed, and how a protein's three-dimensional shape relates to its function. The team plans to extend the technique to related lipid-transport proteins and, ultimately, to explore whether selectively tuning scramblase activity could offer new strategies for treating disease. The tool exists. The deeper work of understanding what to do with it has begun.
Inside the cell membrane, there is constant molecular choreography. Proteins called scramblases are responsible for one of its most essential movements: they reach into the orderly layers of fat molecules that form the membrane's structure and shuffle them around. This disruption sounds chaotic, but it is vital. It enables cells to assemble themselves, to survive, to develop muscle, to traffic molecules where they need to go. For decades, scientists have wanted to watch this process in detail—to measure exactly how fast a single scramblase works. They could not. Now they can.
Researchers at Weill Cornell Medicine and Ruhr University Bochum in Germany have developed the first fluorescence imaging technique capable of measuring the activity of individual scramblase proteins. The work, published in Nature Structural & Molecular Biology, represents a fundamental shift in how cell biologists can observe these proteins at work. Where previous methods forced scientists to study scramblases in bulk—averaging the behavior of many proteins at once—this new approach isolates single proteins and measures their performance with precision. The difference is not merely technical. It reveals variation that bulk methods miss entirely, variation that could reshape how researchers understand what these proteins do and how they malfunction.
The old approach had a clear limitation. Scientists would purify scramblase proteins, place them into tiny artificial membrane spheres called vesicles, and record what happened. But they were always watching an ensemble, a crowd. If one scramblase worked at a different speed than its neighbors, that information was lost in the average. "We were missing what could be large differences between individual scramblase proteins," explained Dr. Anant Menon, a professor of biochemistry and biophysics at Weill Cornell and one of the study's senior authors. Those differences matter. They could illuminate how these proteins actually function and why they sometimes fail.
The new technique works by tagging scramblase proteins with fluorescent markers, embedding them in vesicles, and depositing those vesicles onto a glass slide. Sophisticated microscopy then identifies vesicles containing exactly one scramblase and measures how many lipid molecules that single protein moves per second. The researchers tested their method on two different scramblases. The first was VDAC1, a protein best known for forming channels in the membranes around mitochondria—the cellular power plants. The Menon lab had recently discovered that VDAC1 also functions as a scramblase. When two copies pair up, they create a pathway for lipids to move. The imaging revealed something striking: these pairs work at wildly different rates. Some scramble fewer than 100 lipids per second. Others exceed 1,000. "These findings indicate that only certain dimer conformations are capable of rapid scrambling," Menon said, validating predictions that computer simulations had made but never been proven.
The second test subject was opsin, a light-detecting receptor in the eye that, as Menon's team had shown, also moonlights as a scramblase. Individual opsin molecules proved far more efficient than VDAC pairs. They scramble more than 10,000 lipids per second—an order of magnitude faster. This comparison alone demonstrates the power of the new platform: it can reveal not just how fast a protein works, but how different proteins compare, and how individual molecules within the same protein family vary from one another.
The implications extend well beyond basic science. If researchers can measure scramblase activity with this precision, they can begin to ask new questions. How does changing the composition of the membrane around a scramblase affect its speed? What happens when a drug molecule binds to it? How does the protein's three-dimensional shape relate to how fast it works? The team plans to pursue all of these questions. They also intend to apply the technique to other lipid-transport proteins called flippases and floppases, expanding the toolkit further.
For medicine, the potential is significant. Scramblases are involved in cell survival, protein modification, and countless other processes. If a drug could selectively slow or speed up a particular scramblase, it might offer new ways to treat disease. The technique that makes this possible is now in hand. What remains is the work of understanding what to do with it.
Citas Notables
This new platform is versatile and provides unprecedented information on exactly how fast a single scramblase works.— Dr. Anant Menon, Weill Cornell Medicine
Only certain dimer conformations are capable of rapid scrambling, directly validating predictions from computer simulations.— Dr. Anant Menon
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that we can now watch a single scramblase instead of watching many at once?
Because individual proteins don't all work the same way. When you average a hundred scramblases, you might get a number like 500 lipids per second. But that could hide the fact that half of them work at 100 and half at 900. Those differences tell you something real about how the protein functions—which shapes work best, which conditions matter.
And this variation was invisible before?
Completely invisible. The old methods were like trying to understand traffic patterns by measuring the average speed of all cars on a highway. You miss the fact that some cars are stopped, some are speeding, some are broken down.
What surprised the researchers most?
That VDAC1 dimers showed such a huge range—from under 100 to over 1,000 lipids per second. And that opsin was so much faster, over 10,000. Those numbers suggest the proteins are fundamentally different in how they're built or how they move.
Could this lead to drugs?
That's the hope. If you can measure exactly how fast a scramblase works, you can test whether a drug molecule speeds it up or slows it down. Then you can ask whether slowing it down helps patients with a particular disease.
What's next for the team?
They want to understand why some scramblase shapes work faster than others. They also want to test how changing the lipids around the protein affects its speed, and apply the same technique to other lipid-transport proteins. It's a platform now, not just a one-time measurement.